Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed: 2014-2024

Historic Return on Capital Employed for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to 0.15%.

  • Amphastar Pharmaceuticals' Return on Capital Employed fell 5.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.15% for FY2024, which is 7.00% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.15% for FY2024, which was down 31.41% from 0.22% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Capital Employed registered a high of 0.22% during FY2023, and its lowest value of 0.02% during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Return on Capital Employed averaged around 0.18%, with its median value being 0.18% (2022).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first increased by 11bps in 2021, then decreased by 7bps in 2024.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Return on Capital Employed stood at 0.02% in 2020, then grew by 11bps to 0.13% in 2021, then grew by 5bps to 0.18% in 2022, then rose by 4bps to 0.22% in 2023, then decreased by 7bps to 0.15% in 2024.